Pediatrix Medical Group, Inc.

MD Healthcare Medical Care Facilities

Pediatrix Medical Group, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $1.9 billion, down 4.92% from fiscal 2024. In the quarter to June 2026, revenue grew 4.04%, EPS grew 6.52%, free cash flow fell 6.56% and total debt fell 3.84%, each against the same quarter a year earlier.

27.38 0.38 −1.37%
Market cap
$2.3B
P/E
13.1×
Fwd P/E
11.3×
Dividend yield
—
F-score
7/9
Altman Z
2.05
Beneish M
−2.86
Dividend safety
n/a
Jun '26 Mar '26 Dec '25 Sep '25 Older periods
P/E ratio
12.12 10.38 11.03 8.82

+8 more quarters

P/S ratio
1.03 0.90 0.94 0.74
P/FCF ratio
8.80 7.29 7.12 5.18
P/Operating CF
16.06 (13.32) 15.76 10.32
P/B ratio
2.28 1.97 2.08 1.59
Price to Tangible BV
0.00 0.00 0.00 0.00
EV/Sales
1.12 1.03 0.99 0.81
EV/EBITDA
9.17 8.24 8.19 6.97
EV/Operating CF
8.88 7.70 6.99 5.37
EV/FCF
9.59 8.39 7.51 5.69
Quick Ratio
1.28 1.28 1.62 1.78
Current Ratio
1.32 1.33 1.66 1.83
Net Debt/EBITDA
2.87 5.47 1.79 1.89
Debt/Assets
27.42% 28.54% 26.59% 27.39%
Debt/Equity
0.66 0.67 0.69 0.68
Asset Turnover
0.92 0.95 0.87 0.90
Operating CF/Net income
3.15 (4.39) 3.39 1.91
Capex/Depreciation
(0.24) (1.00) (0.90) (0.92)
Interest Coverage
6.97 5.04 5.58 7.61
Research and Development Expense of Revenue
0.00% 0.00% 0.00% 0.00%
Selling, General and Administrative Expense of Revenue
12.57% 12.66% 13.30% 12.33%
Intangible Assets out of Total Assets
0.60 0.62 0.57 0.58
Share Based Compensation of Revenue
1.04% 0.98% 1.08% 1.04%
Graham Net Nets
(0.29) (0.35) (0.34) (0.42)
Graham Number
22.84 22.44 21.20 21.21
Earnings Yield
8.25% 9.63% 9.07% 11.34%
Free Cash Flow Yield
11.36% 13.72% 14.05% 19.29%
Revenue per Share
6.14 5.89 5.87 5.83
Operating CF per Share
1.58 (1.61) 1.36 1.62
Capex per Share
(0.02) (0.08) (0.06) (0.06)
Free Cash Flow per Share
1.56 (1.68) 1.29 1.56
Cash per Share
5.09 4.07 5.94 5.47
Shareholders Equity per Share
11.09 10.86 10.30 10.53
Interest Debt per Share
0.00 0.00 0.00 0.00
Book value per Share
11.09 10.86 10.30 10.53
Free Cash Flow
123.94 (136.09) 108.82 131.95
Working Capital
158.56 144.40 304.60 324.65
Capital Expenditures
(1.38) (6.25) (5.29) (5.34)
Net Current Asset Value
(589.22) (604.68) (617.33) (591.54)
EV/EBIT
10.18 9.12 9.08 7.81
Capex to Sales
0.00 0.01 0.01 0.01
Price to Operating Income
9.34 7.92 8.61 7.11
Other line items
Average Receivables
242.81 244.90 257.46 261.52
Average Payables
302.60 235.55 409.11 342.86
Average Assets
2,116.22 2,031.89 2,199.70 2,138.14
Average Common Equity
857.37 833.88 815.40 811.58

Fold the line items

Columns are period end dates